Lorazepam Tablet
Product Images NDC 67296-1629

2 FDA label images from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 67296-1629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular (Lorazepam Molecular)

Molecular (Lorazepam Molecular)
Chemical structure of Lorazepam illustrating its molecular formula C15H10Cl2N2O2 and molecular weight of 321.16. The diagram shows the arrangement of two chlorinated benzene rings, a nitrogen-containing ring, and other functional groups.*
FDA Label Image

Label (Lorazepam 1629)

Label (Lorazepam 1629)
Lorazepam 0.5 mg oral tablets packaged in a blister strip of 10 tablets. The label shows the product's NDC 67296-1629-1, indicates Rx only status, lot number J03318X1, and expiration date 09/21. Manufacturer is Leading Pharma LLC, Fairfield, NJ, and distributor is Redpharm Drug, Eden Prairie, MN. Storage instructions specify controlled room temperature 20-25°C (68-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.